Search
Ad5-nCoV
go.drugbank.com/drugs/DB15655Investigational[L12675,L12678] It is being developed by CanSino Biologics Inc., in partnership with the Beijing Institute of Biotechnology, who in March 2020 announced the approval of a phase I clinical trial (ChiCTR2000030906 … The study will evaluate antibody response in healthy patients between the ages of 18 and 60 who will receive one of three study doses, with follow-up taking place at weeks 2 and 4 and months 3 and 6 post-vaccination
Dihydroxyacetone
go.drugbank.com/drugs/DB01775ExperimentalIts addition to blood preservation solutions results in better maintenance of 2,3-diphosphoglycerate levels during storage. … It is readily phosphorylated to dihydroxyacetone phosphate by triokinase in erythrocytes. In combination with naphthoquinones it acts as a sunscreening agent. [PubChem]
Contusugene ladenovec
go.drugbank.com/drugs/DB05322InvestigationalINGN 201(Advexin) is a replication-impaired adenoviral vector that carries the p53 gene, has been evaluated in both preclinical and clinical trials.
Alfaxalone
go.drugbank.com/drugs/DB11371ExperimentalVet approvedAlong with alfadolone, it is also one of the constituents of anesthetic drug mixture althesin. … It is used in veterinary practice under the trade name Alfaxan, and is licensed for use in both dogs and cats.
Enecadin
go.drugbank.com/drugs/DB13032InvestigationalEnecadin has been investigated for the treatment of Stroke.
Vinpocetine
go.drugbank.com/drugs/DB12131InvestigationalVinpocetine has been investigated for the treatment of Epilepsy.
GW-870086
go.drugbank.com/drugs/DB12322InvestigationalGW870086X has been investigated for the treatment of ASTHMA.
Ipamorelin
go.drugbank.com/drugs/DB12370InvestigationalIpamorelin has been investigated for the treatment of Ileus.
Modufolin
go.drugbank.com/drugs/DB12676InvestigationalModufolin is under investigation for the treatment of Osteosarcoma.
Vestipitant
go.drugbank.com/drugs/DB11949InvestigationalVestipitant has been investigated for the treatment of Tinnitus.
Categories: Neurokinin-1 Receptor Antagonists